ELM-PC5_2B: ELM-PC5, figure 2B

ELM-PC5_2BR Documentation

ELM-PC5, figure 2B

Description

Kaplan-Meier digitized data from ELM-PC5, figure 2B (PMID 25624429). A reported sample size of 1,099 for a primary endpoint of OS in prostate cancer.

Usage

`ELM-PC5_2B`

Format

A data frame of 1,099 observations and 3 variables:

time event time (in months)
event PFS event indicator (0: no event, 1: event)
arm treatment arms (orteronel, placebo)

Source

Fizazi K, Jones R, Oudard S, et al. Phase III, randomized, double-blind, multicenter trial comparing orteronel (TAK-700) plus prednisone with placebo plus prednisone in patients with metastatic castration-resistant prostate cancer that has progressed during or after docetaxel-based therapy: ELM-PC 5. J Clin Oncol 2015; 33: 723–31.

Examples

summary(`ELM-PC5_2B`)

kmplot(`ELM-PC5_2B`)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.